{"brief_title": "High-dose ICE With Amifostine", "brief_summary": "The purpose of the study is to evaluate the combination of amifostine and high dose chemotherapy with blood stem cell support. Amifostine is a druf developed to protect normal tissues against the toxicities of chemotherapy and radiotherapy and has reduced the side effects of chemotherapy given at conventional doses.", "condition": "Unspecified Adult Solid Tumor, Protocol Specific", "intervention_type": "Procedure", "intervention_name": "peripheral blood stem cell transplantation", "arm_group_label": "High Dose ICF with Amifostine", "other_name": "Ifex", "criteria": "Eligibility Criteria: - Histologically documented malignancy - Metastatic or locally unresectable malignancy - Patient may be responding to therapy - Responding Stage IIIC/IV or recurrent/refractory ovarian carcinoma (ineligible for other bone marrow or stem cell transplant protocols) - Relapsed germ cell carcinomas - Relapsed lymphomas (ineligible for other BMT or SCT protocols - SCLC in PR or CR - Sarcomas in or near complete remission after induction chemotherapy - Stage IIIB NSCLC responding to chemotherapy - Responsive bladder, head and neck carcinoma, or carcinoma of unknown primary - Other tumors without curative or first line therapy (not eligible for phase II or III studies) - Aged 18 to 55 Physiologic years -- Performance status: PS 0-1 - Prior Treatment - > 1 week since surgery or RT - > 3 weeks since prior CT - Informed Consent - Required initial laboratory data: - White Cell Count Life \u2265 3000/ul - Platelet Count \u2265 100,000/ul - Creatinine \u2264 1.5 x normal - Bilirubin \u2264 1.5 x normal - No current metastases - BM Asp & Bx - Brain CAT - Creatinine Clearance \u2265 60 cc/min - SGOT < 2.5 x normal - No other serious medical or psychiatric illness which would prevent informed consent or general anesthesia - Uncontrolled or severe cardiovascular disease including recent (< 6 months) myocardial infarction, or congestive heart failure - Active uncontrolled bacterial, viral, or fungal infection; or an active duodenal ulcer; until these conditions are corrected or controlled - Pregnancy - Unable to stop taking antihypertensive medication 24 hours prior to administration of Ethyol", "gender": "All", "minimum_age": "18 Years", "maximum_age": "55 Years", "healthy_volunteers": "No", "id": "NCT00003657.xml"}